Abstract
Patients with vaginitis due to highly azole resistant Candida glabrata can be particularly difficult to treat. We describe three cases of longstanding vaginal candidiasis due to C glabrata. These had failed to respond to local and systemic antifungals. Flucytosine (1 g) and amphotericin B (100 mg) formulated in lubricating jelly base in a total 8 g delivered dose, was used per vagina once daily for 14 days with significant improvement, both clinically and microbiologically.
Key Words: amphotericin; flucytosine; Candida glabrata
Full Text
The Full Text of this article is available as a PDF (79.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bingham J. S. What to do with the patient with recurrent vulvovaginal candidiasis. Sex Transm Infect. 1999 Aug;75(4):225–227. doi: 10.1136/sti.75.4.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fidel P. L., Jr, Vazquez J. A., Sobel J. D. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev. 1999 Jan;12(1):80–96. doi: 10.1128/cmr.12.1.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Geiger A. M., Foxman B., Sobel J. D. Chronic vulvovaginal candidiasis: characteristics of women with Candida albicans, C glabrata and no candida. Genitourin Med. 1995 Oct;71(5):304–307. doi: 10.1136/sti.71.5.304. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Horowitz B. J. Topical flucytosine therapy for chronic recurrent Candida tropicalis infections. J Reprod Med. 1986 Sep;31(9):821–824. [PubMed] [Google Scholar]
- Kerridge D., Nicholas R. O. Drug resistance in the opportunistic pathogens Candida albicans and Candida glabrata. J Antimicrob Chemother. 1986 Oct;18 (Suppl B):39–49. doi: 10.1093/jac/18.supplement_b.39. [DOI] [PubMed] [Google Scholar]
- Lynch M. E., Sobel J. D. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates. J Med Vet Mycol. 1994;32(4):267–274. [PubMed] [Google Scholar]
- Otero L., Fleites A., Méndez F. J., Palacio V., Vázquez F. Susceptibility of Candida species isolated from female prostitutes with vulvovaginitis to antifungal agents and boric acid. Eur J Clin Microbiol Infect Dis. 1999 Jan;18(1):59–61. doi: 10.1007/s100960050227. [DOI] [PubMed] [Google Scholar]
- Redondo-Lopez V., Lynch M., Schmitt C., Cook R., Sobel J. D. Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents. Obstet Gynecol. 1990 Oct;76(4):651–655. [PubMed] [Google Scholar]
- White D. J., Johnson E. M., Warnock D. W. Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata. Genitourin Med. 1993 Apr;69(2):112–114. doi: 10.1136/sti.69.2.112. [DOI] [PMC free article] [PubMed] [Google Scholar]